Publications by authors named "Lorenza Ferrillo"

Claim this Profile
C
Case Series on the Combined Therapy with Elexacaftor/Tezacaftor/Ivacaftor During Pregnancy in Women with Severe Cystic Fibrosis: A Retrospective Report from an Italian Centre.
Paola Iacotucci, Jolanda Somma, Lorenza Ferrillo, Assunta Celardo, Valeria Conti

J Clin Med· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of Oral Amino Acid Supplementation on Physical Activity, Systemic Inflammation, and Quality of Life in Adult Patients with Cystic Fibrosis: A Single-Center, Randomized, Double-Blind, Placebo-Controlled Pilot Study.
Laura Petraglia, Paola Iacotucci, Lorenza Ferrillo, Serena Cabaro, Jolanda Somma

Nutrients· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Beneficial economic effect of a virtual model of care for cystic fibrosis.
Paola Iacotucci, Vincenzo Carnovale, Dandi Qiao, Lorenza Ferrillo, Alessandro Sanduzzi Zamparelli

Pediatr Pulmonol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cystic Fibrosis in Adults: A Paradigm of Frailty Syndrome? An Observational Study.
Paola Iacotucci, Vincenzo Carnovale, Lorenza Ferrillo, Jolanda Somma, Marialuisa Bocchino

J Clin Med· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical outcomes of digital health in adults with cystic fibrosis.
Vincenzo Carnovale, Paola Iacotucci, Dandi Qiao, Lorenza Ferrillo, Jolanda Somma

Respir Med· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness and safety of elexacaftor/tezacaftor/ivacaftor in patients with cystic fibrosis and advanced lung disease with the Phe508del/minimal function genotype.
Vincenzo Carnovale, Paola Iacotucci, Vito Terlizzi, Carmela Colangelo, Pietro Medio, Lorenza Ferrillo

Respir Med· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elexacaftor/Tezacaftor/Ivacaftor in Patients with Cystic Fibrosis Homozygous for the Mutation and Advanced Lung Disease: A 48-Week Observational Study.
Vincenzo Carnovale, Paola Iacotucci, Vito Terlizzi, Carmela Colangelo, Lorenza Ferrillo

J Clin Med· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis